Cullinan Therapeutics, Inc. CGEM Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s common stock?
- Cullinan Therapeutics, Inc. (CGEM) reported common stock of $6K in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s common stock changed year-over-year?
- Cullinan Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from $6K to $6K.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s common stock has grown at a 14.9% compound annual growth rate (CAGR), from $3K to $6K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).